Cargando…

Pathogenetic Mechanisms Underlying Major Adverse Cardiac Events in Personality Type D Patients after Percutaneous Coronary Intervention: The Roles of Cognitive Appraisal and Coping Strategies

Background: This paper aimed to study the association of type D personality, coping strategies, and cognitive appraisal with annual prognosis after a percutaneous coronary intervention (PCI) in patients with coronary artery disease (CAD). Methods: The prospective study included 111 CAD patients who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sumin, Alexey N., Shcheglova, Anna V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648350/ https://www.ncbi.nlm.nih.gov/pubmed/37958270 http://dx.doi.org/10.3390/diagnostics13213374

Ejemplares similares

Evaluation of Coping Strategies among Students with Type D Personality
por: Sumin, Alexey N., et al.
Publicado: (2022)

Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
por: Ikebe, So, et al.
Publicado: (2023)

The SYNTAX Score Can Predict Major Adverse Cardiac Events Following Percutaneous Coronary Intervention
por: Safarian, Hadi, et al.
Publicado: (2014)

A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention
por: Kassaian, Seyed-Ebrahim, et al.
Publicado: (2015)

The Personality and Psychological Stress Predict Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention for Five Years
por: Du, Jinling, et al.
Publicado: (2016)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
por: Chen, Zhihao, et al.
Publicado: (2018)

The burden of major adverse cardiac events in patients with coronary artery disease
por: Tsai, I-Ting, et al.
Publicado: (2017)

Mean Platelet Volume as a Predictor of One-Year Major Adverse Cardiac Events following Elective Percutaneous Coronary Interventions
por: Nozari, Younes, et al.
Publicado: (2014)

The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention
por: Zhang, Zhaowei, et al.
Publicado: (2020)

Major adverse cardiac events and drug-coated balloon size in coronary interventions
por: Naguib, David, et al.
Publicado: (2018)

Percutaneous Coronary Intervention using a Full Metal Jacket with Drug-eluting Stents: Major Adverse Cardiac Events at One Year
por: Calé, Rita, et al.
Publicado: (2013)

Serum Apelin Level Predicts the Major Adverse Cardiac Events in Patients With ST Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention
por: Liu, Hai-Tao, et al.
Publicado: (2015)

Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention
por: Pan, Defeng, et al.
Publicado: (2021)

Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
por: Cai, Anping, et al.
Publicado: (2019)

Associations of Modified Healthy Aging Index With Major Adverse Cardiac Events, Major Coronary Events, and Ischemic Heart Disease
por: Huang, Ninghao, et al.
Publicado: (2023)

Major adverse cardiac events and mortality in chronic obstructive pulmonary disease following percutaneous coronary intervention: a systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Predictors of major adverse cardiac events following elective stenting of large coronary arteries
por: Aghajani, Hassan, et al.
Publicado: (2018)

Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation
por: Jung, Richard G, et al.
Publicado: (2022)

Indicators of the Right Ventricle Systolic and Diastolic Function 18 Months after Coronary Bypass Surgery
por: Sumin, Alexey N., et al.
Publicado: (2022)

Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Zhu, Kun, et al.
Publicado: (2020)

Long-Term Prognosis after Coronary Artery Bypass Grafting: The Impact of Arterial Stiffness and Multifocal Atherosclerosis
por: Sumin, Alexey N., et al.
Publicado: (2022)

The Outcomes of Coronary Artery Bypass Surgery after 18 Months—Is There an Influence of the Initial Right Ventricle Diastolic Dysfunction?
por: Sumin, Alexey N., et al.
Publicado: (2023)

Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study
por: Farshidi, Hossein, et al.
Publicado: (2018)

Older Couples Coping With Adverse Life Events: The Importance of Dyadic Personality Profiles
por: Wang, Shuangshuang, et al.
Publicado: (2020)

The Burden of Short-term Major Adverse Cardiac Events and its Determinants after Emergency Percutaneous Coronary Revascularization: A Prospective Follow-up Study
por: Kumar, Rajesh, et al.
Publicado: (2022)

Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome
por: Baluja, Aurora, et al.
Publicado: (2019)

A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
por: Kong, Shuting, et al.
Publicado: (2021)

Elevated Baseline Serum Fibrinogen: Effect on 2‐Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention
por: Ang, Lawrence, et al.
Publicado: (2017)

Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention
por: Ramesh, S., et al.
Publicado: (2020)

Intelligent prediction of major adverse cardiovascular events (MACCE) following percutaneous coronary intervention using ANFIS-PSO model
por: Dehdar Karsidani, Sahar, et al.
Publicado: (2022)

Effects of High- or Moderate-intensity Rosuvastatin on 1-year Major Adverse Cardiovascular Events Post-percutaneous Coronary Intervention
por: Chehrevar, Morteza, et al.
Publicado: (2022)

Assessment of Arterial Stiffness by Cardio-Ankle Vascular Index for Prediction of Five-Year Cardiovascular Events After Coronary Artery Bypass Surgery
por: Sumin, Alexei N., et al.
Publicado: (2021)

A Propensity Score Matched Analysis of Statin Effects on Major Adverse Cardiac Events after Percutaneous Coronary Intervention in Patients Over 75 Years Old
por: Horikoshi, Takeo, et al.
Publicado: (2022)

Development and Validation of a Prediction Rule for Major Adverse Cardiac and Cerebrovascular Events in High-Risk Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention
por: Zhao, Xiaoxiao, et al.
Publicado: (2022)

Appraisal of Intraoperative Adverse Events to Improve Postoperative Care
por: Gawria, Larsa, et al.
Publicado: (2023)

Prognostic Impact of Red Cell Distribution Width on the Development of Contrast-Induced Nephropathy, Major Adverse Cardiac Events, and Mortality in Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention
por: Latif, Azka, et al.
Publicado: (2021)

Cognitive appraisals, objectivity and coping in ambulance workers: a pilot study
por: Shepherd, Laura, et al.
Publicado: (2014)

Types of Cognitive Appraisal and Undertaken Coping Strategies during Sport Competitions
por: Litwic-Kaminska, Kamila
Publicado: (2020)

Association of smoking with restenosis and major adverse cardiac events after coronary stenting: A meta-analysis
por: Hu, Rui-ting, et al.
Publicado: (2015)

Major adverse cardiac event rates in moderate‐risk patients: Does prior coronary disease matter?
por: McGinnis, Henderson D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5mnec8ejk1fe2fhr6olb7e21b9